Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population

Genes and Immunity

Volumn 10, Issue 3, 2009, Pages 260-266

  Chu, X ^a,b,d   Dong, C ^b   Lei, R ^a   Sun, L ^b   Wang, Z ^b   Dong, Y ^a   Shen, M ^b   Wang, Y ^b   Wang, B ^b   Zhang, K ^b   Yang, L ^b   Li, Y ^b   Yuan, W ^b   Song, H ^b   Jin, L ^a   Xiong, M ^b,c   Huang, W ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINESE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHILD; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HUMANS; INTERLEUKIN-3; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 67349133137     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.3     Document Type: Article

References (36)

1. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA et al. Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499.
2. Zhang K LY, Fang Z, Luo C, Liu X, Zhang F, Chen G et al. The effect of salt iodization for 10 years on the prevalences of endemic goiter and hyperthyroidism. Chin J Endocrinol Metab 2002; 18 342-344.
3. Jin Y, Teng W, Ben S, Xiong X, Zhang J, Xu S et al. Genomewide scan of Graves' disease: Evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. J Clin Endocrinol Metab 2003; 88: 1798-1803.
4. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 2001; 10 1379-1386.
5. Akamizu T, Hiratani H, Ikegami S, Rich SS, Bowden DW. Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients. J Hum Genet 2003; 48: 236-242.
6. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 1984-1988.
7. Hiromatsu Y, Fukutani T, Ichimura M, Mukai T, Kaku H, Nakayama H et al. Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease. J Clin Endocrinol Metab 2005; 90: 296-301.
8. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001; 2: 802-809.
9. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW et al. Replication of putative candidate-gene associations with rheumatoid arthritis in>4000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-1060.
10. Yamada R, Tanaka T, Unoki M, Nagai T, Sawada T, Ohnishi Y et al. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 2001; 68; 674-685.
11. Park BL, Kim LH, Choi YH, Lee JH, Rhim T, Lee YM et al. Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy. J Hum Genet 2004; 49: 517-527.
12. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471-475.
13. Silverberg MS, Duerr RH, Brant SR, Bromfield G, Datta LW, Jani N et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet 2007; 15: 328-335.
14. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003; 35: 341-348.
15. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997; 6: 681-689.
16. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve - an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
17. DeRijk RH, Schaaf M, de Kloet ER. Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 2002; 81: 103-122.
18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
19. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
20. Schweiger A, Stern D, Lohman IC, Baldini M, Martinez FD, Halonen M. Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3. J Allergy Clin Immunol 2001; 107: 505-510.
21. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: Results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003; 73: 736-747.
22. Taylor JC, Gough SC, Hunt PJ, Brix TH, Chatterjee K, Connell JM et al A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 2006; 91: 646-653.
23. Hawwari A, Burrows J, Vadas MA, Cockerill PN. The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities. J Immunol 2002; 169: 1876-1886.
24. Dogan RN, Vasu C, Holterman MJ, Prabhakar BS. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 2003; 170: 2195-2204.
25. Ebner S, Hofer S, Nguyen VA, Furhapter C, Herold M, Fritsch P et al A novel role for IL-3: Human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol 2002; 168: 6199-6207.
26. Nakkuntod J, Wongsurawat T, Charoenwongse P, Snabboon T, Sridama V, Hirankarn N. No association between an interleukin 4 gene promoter (-589) polymorphism and Graves' disease in Thai patients. J Med Assoc Thai 2004; 87 (Suppl 2): S123-S128.
27. Yang Y, Lingling S, Ying J, Yushu L, Zhongyan S, Wei H et al. Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease. J Hum Genet 2005; 50: 574-582.
28. Shiau MY, Huang CN, Yang TP, Hwang YC, Tsai KJ, Chi CJ et al. Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease. Clin Biochem 2007; 40: 213-217.
29. Chen RH, Chang CT, Wang TY, Chen CC, Tsai CH, Tsai FJ. Lack of association between interleukin-4 gene polymorphisms and autoimmune thyroid diseases amongst Taiwanese Chinese. Endocrine 2007; 32 170-174.
30. Bednarczuk T, Placha G, Jazdzewski K, Kurylowicz A, Kloza M, Makowska U et al. Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin Endocrinol (Oxf) 2003; 59: 519-525.
31. Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ et al. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci 2008; 49: 2409-2415.
32. Simmonds MJ, Heward JM, Franklyn JA, Gough SC. IL-13 and chromosome 5q31-q33: Problems of identifying association within regions of linkage to Graves' disease. Clin Endocrinol (Oxf) 2005; 63: 695-697.
33. Tello-Ruiz MK, Curley C, DelMonte T, Giallourakis C, Kirby A, Miller K et al. Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur J Hum Genet 2006; 14: 780-790.
34. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
35. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-1223.
36. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.